Vertex Pharmaceuticals Incorporated (VRTX) forecast

Vertex Pharmaceuticals Incorporated (VRTX) forecast: price $536.15, trailing P/E 30.28, forward P/E 28.69. How to read the street's path.

$536.15Price
$135.89BMarket cap
30.28P/E ?
28.69Forward P/E ?
0.00%Dividend yield ?

The live VRTX price is $536.15. Trailing P/E is 30.28 and forward P/E is 28.69. The forecast that matters is the earnings path those ratios imply, not a single target price.

A forward P/E below the trailing P/E means the consensus expects earnings to rise. The reverse means the market is looking at a peak. Neither is a schedule. Analyst targets are useful as a range of models. They are not a contract. Discounted cash flow is the long form: cash flows, a discount rate, and a terminal value you can argue with.

Use this page for the VRTX forecast URL. The prediction page next to it puts the same live inputs in the price-target framing. Both stay in sync with the quote on the main page.

Learn: Forward P/E · Analyst forecast · DCF

Full VRTX quote · Dividends · Price prediction · Academy

Questions

What is VRTX's forward P/E?

The latest forward P/E on Stocklytics is 28.69, against a trailing P/E of 30.28 and a price of $536.15.

Is the analyst target the forecast?

It is one forecast. The earnings estimate behind it is the part you can track. The target will be revised after the next report.